1. Quality by Design (QbD) application for the pharmaceutical development process

   • Sang-Ho Lee
   • Jin-Ki Kim
   • Joo-Eun Kim

   Review 29 August 2022 Pages: 649 - 682

   

2. Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research

   • Alam Zeb
   • Maleeha Gul
   • Han-Joo Maeng

   Review 09 July 2022 Pages: 683 - 724

   

3. Tumor-originated pH-responsive nanovaccine mixture to treat heterogeneous tumors

   • Jaeduk Park
   • Eunsol Lee
   • Eun Seong Lee

   Original Article 07 July 2022 Pages: 725 - 737

   

4. Impact of buffer concentration on the thermal stability of immunoglobulin G

   • Soo Hyun Kim
   • Han Ju Yoo
   • Dong Hee Na

   Original Article 26 July 2022 Pages: 739 - 747

   

5. Catalase-mimicking synthetic nano-enzymes can reduce lipopolysaccharide-induced reactive oxygen generation and promote rapid detection of hydrogen peroxide and l-cysteine

   • Vishnu Revuri
   • Jagannath Mondal
   • Yong-kyu Lee

   Original Article 16 August 2022 Pages: 749 - 764

   

6. Intranasal administration of an aronia extract and carrageenan nanocomposite for the prevention of influenza A H1N1 virus infection

   • Jangsu Lee
   • Kyoung Sub Kim
   • Kun Na

   Original Article 08 August 2022 Pages: 765 - 774

   

7. Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cancer

   • Reeju Amatya
   • Doyeon Kim
   • Meong Cheol Shin

   Original Article 01 August 2022 Pages: 775 - 785

   

8. A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor

   • Farah Rehan
   • Md. Emranul Karim
   • Ezharul Hoque Chowdhury

   Original Article Open access 10 September 2022 Pages: 787 - 804